ES8400441A1 - "procedimiento para la produccion de 1-azaxantona". - Google Patents
"procedimiento para la produccion de 1-azaxantona".Info
- Publication number
- ES8400441A1 ES8400441A1 ES515897A ES515897A ES8400441A1 ES 8400441 A1 ES8400441 A1 ES 8400441A1 ES 515897 A ES515897 A ES 515897A ES 515897 A ES515897 A ES 515897A ES 8400441 A1 ES8400441 A1 ES 8400441A1
- Authority
- ES
- Spain
- Prior art keywords
- azaxanthone
- processes
- production
- pharmaceutical compositions
- therapeutic agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- YAUODDQCNOBEDJ-UHFFFAOYSA-N chromeno[3,2-b]pyridin-10-one Chemical compound C1=CN=C2C(=O)C3=CC=CC=C3OC2=C1 YAUODDQCNOBEDJ-UHFFFAOYSA-N 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 229940124597 therapeutic agent Drugs 0.000 title 1
- 239000002253 acid Substances 0.000 abstract 2
- 229920000137 polyphosphoric acid Polymers 0.000 abstract 2
- XLYOFNOQVPJJNP-PWCQTSIFSA-N Tritiated water Chemical compound [3H]O[3H] XLYOFNOQVPJJNP-PWCQTSIFSA-N 0.000 abstract 1
- 230000001351 cycling effect Effects 0.000 abstract 1
- 239000012024 dehydrating agents Substances 0.000 abstract 1
- 238000010438 heat treatment Methods 0.000 abstract 1
- 239000011541 reaction mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Cephalosporin Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP81107651A EP0075607B1 (en) | 1981-09-25 | 1981-09-25 | 1-azaxanthone for use as therapeutic agent, processes for its production and pharmaceutical compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES515897A0 ES515897A0 (es) | 1983-11-16 |
| ES8400441A1 true ES8400441A1 (es) | 1983-11-16 |
Family
ID=8187931
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES515897A Expired ES8400441A1 (es) | 1981-09-25 | 1982-09-23 | "procedimiento para la produccion de 1-azaxantona". |
| ES515898A Expired ES8308886A1 (es) | 1981-09-25 | 1982-09-23 | "procedimiento para la produccion de 1-azaxantona". |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES515898A Expired ES8308886A1 (es) | 1981-09-25 | 1982-09-23 | "procedimiento para la produccion de 1-azaxantona". |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US4623648A (enExample) |
| EP (1) | EP0075607B1 (enExample) |
| JP (1) | JPS5867618A (enExample) |
| AT (1) | ATE12072T1 (enExample) |
| DE (1) | DE3169269D1 (enExample) |
| ES (2) | ES8400441A1 (enExample) |
| PT (2) | PT75582A (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1200085B (it) * | 1984-07-12 | 1989-01-05 | Sandoz Ag | Procedimento per la preparazione di xantoni e di tioxantoni |
| US5565413A (en) * | 1994-12-06 | 1996-10-15 | Zeneca Limited | Substituted pyridyl phenyl ketone herbicides |
| ATE300293T1 (de) * | 1997-03-03 | 2005-08-15 | Sanofi Aventis | Pharmazeutische zusammensetzungen, die schwerlösliche arzneistoffe enthalten |
| EP1554572B1 (en) | 2001-07-25 | 2009-10-14 | Raptor Pharmaceutical Inc. | Compositions and methods for modulating blood-brain barrier transport |
| DK1889198T3 (da) | 2005-04-28 | 2015-02-09 | Proteus Digital Health Inc | Farma-informatiksystem |
| KR20090071598A (ko) | 2006-09-18 | 2009-07-01 | 랩터 파마슈티컬 인코포레이티드 | 수용체 결합 단백질(ｒａｐ)-접합체 투여에 의한 간 질환의 치료 |
| WO2010095940A2 (en) | 2009-02-20 | 2010-08-26 | To-Bbb Holding B.V. | Glutathione-based drug delivery system |
| TWI556839B (zh) | 2009-05-06 | 2016-11-11 | 研究室護膚股份有限公司 | 包含活性劑－磷酸鈣粒子複合物之皮膚遞送組成物及其使用方法 |
| US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3803153A (en) | 1970-11-16 | 1974-04-09 | Schering Corp | Benzopyrano pyridines |
| JPS5619350B2 (enExample) * | 1972-07-21 | 1981-05-07 | ||
| JPS5919113B2 (ja) * | 1975-02-03 | 1984-05-02 | ウェルファイド株式会社 | 新規なベンゾピラノピリジン誘導体の製法 |
| JPS5195097A (ja) * | 1975-02-08 | 1976-08-20 | Benzopiranopirijinjudotainoseizoho |
-
1981
- 1981-09-25 AT AT81107651T patent/ATE12072T1/de not_active IP Right Cessation
- 1981-09-25 EP EP81107651A patent/EP0075607B1/en not_active Expired
- 1981-09-25 DE DE8181107651T patent/DE3169269D1/de not_active Expired
-
1982
- 1982-09-21 PT PT75582A patent/PT75582A/pt unknown
- 1982-09-21 PT PT75581A patent/PT75581B/pt not_active IP Right Cessation
- 1982-09-23 ES ES515897A patent/ES8400441A1/es not_active Expired
- 1982-09-23 ES ES515898A patent/ES8308886A1/es not_active Expired
- 1982-09-24 JP JP57167442A patent/JPS5867618A/ja active Granted
-
1984
- 1984-11-05 US US06/668,179 patent/US4623648A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US4623648A (en) | 1986-11-18 |
| DE3169269D1 (en) | 1985-04-18 |
| JPH0354645B2 (enExample) | 1991-08-20 |
| PT75582A (fr) | 1982-10-01 |
| ES515897A0 (es) | 1983-11-16 |
| PT75581A (fr) | 1982-10-01 |
| PT75581B (fr) | 1985-05-31 |
| EP0075607A1 (en) | 1983-04-06 |
| JPS5867618A (ja) | 1983-04-22 |
| ES515898A0 (es) | 1983-10-16 |
| ES8308886A1 (es) | 1983-10-16 |
| ATE12072T1 (de) | 1985-03-15 |
| EP0075607B1 (en) | 1985-03-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8400441A1 (es) | "procedimiento para la produccion de 1-azaxantona". | |
| FR2428025B1 (enExample) | ||
| DE3061419D1 (en) | Process for preparing pure cyanuric acid | |
| SE7703617L (sv) | Forfarande for framstellning av 2-klornikotinsyra | |
| ES508421A0 (es) | "procedimiento para la preparacion de cloruro de 2-hidroxi-3-cloropropiltrialcohilamonio". | |
| GB999253A (en) | Novel unsaturated esters and a process for the preparation thereof | |
| UA7014A1 (uk) | Спосіб отримання 4-аміно-5-хлор-1-фенілпірідазона-(6) | |
| ATE17573T1 (de) | Verfahren zur herstellung von reinem diacetonitril. | |
| JPS5673081A (en) | Preparation of tocopherol acetate | |
| SE8502859D0 (sv) | Forfarande for framstellning av ett vermeisolerande material | |
| DK551384A (da) | Lorazepamholdigt sovemiddel og fremgangsmaade til dets fremstilling | |
| SU598865A1 (ru) | "Способ получени 13-кетобицикло (10,3,0)-1 | |
| SU662517A1 (ru) | Газообразный реагент дл обработки стекла | |
| SU381655A1 (ru) | Сырьевая смесь для получения теплоизоляционного | |
| ES8605666A1 (es) | Procedimiento de preparar concentrados proteicos y preparaciones alimenticias. | |
| GB920737A (en) | Process for n-methylacridone | |
| GB924955A (en) | A process for the manufacture of a derivative of vitamin b containing sulphur | |
| JPS5687556A (en) | Preparation of aziridine-2-carboxylate | |
| JPS57102875A (en) | 5-acylamino-4-methyloxazole and its preparation | |
| ES320115A1 (es) | Procedimiento para la preparaciën de dicloropiracinas | |
| JPS54151195A (en) | Production of phenylphenol | |
| GB759316A (en) | Improvements in and relating to derivatives of purine | |
| SE7602395L (sv) | Nytt sett att framstella 2-guanidinometyl-perhydroazocinsulfat | |
| GB1116126A (en) | Process for the preparation of a mercapto-thiophosphoric acid ester | |
| GB1491649A (en) | Process for the preparation of bromoacetic acid and esters thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD1A | Patent lapsed |
Effective date: 19970519 |